Mueller T, Fischer A B, Yamamoto T. "一种的合成方法" [P]. US Patent, US 9211153 B2, 2022-02-05.
Nielsen H, Jørgensen K, Björnsson E. "Method for the Synthesis of 2-(1-(4-Chlorobenzyl)-2,5-dimethyl-1h-indol-3-yl)-N-(2-methoxypyridin-4-yl)-2-oxoacetamide" [P]. European Patent, EP 3763535 A1, 2024-08-24.
发明人王建平,韩伟,陈志强. "A Process for Preparing High-Purity 2-(1-(4-Chlorobenzyl)-2,5-dimethyl-1h-indol-3-yl)-N-(2-methoxypyridin-4-yl)-2-oxoacetamide" [P]. 中国发明专利, 专利号 CN 110272751 A, 授权公告日 2018-07-08.
参考文献 Literature
Brown R C, Davis S M. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Pharm. Biomed. Anal., 2016, 1844, 7904-7910.
Brown R C, Davis S M. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Anal. Methods, 2016, 1988, (9), 5467-5492.
Chen X Y, Liu M, Zhao W Q. "Identification and Structural Characterization of a Novel Degradation Product of 2-(1-(4-Chlorobenzyl)-2,5-dimethyl-1h-indol-3-yl)-N-(2-methoxypyridin-4-yl)-2-oxoacetamide Using HRMS and NMR". J. Chromatogr. A, 2017, 83, 5991-5995.
Brown R C, Davis S M. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". J. Nat. Prod., 2010, 1287, 7975-8005.